Autonomic Testing for Syncope and Unexplained Falls in Neurology

Clinical Challenges in Syncope and Fall Evaluation

For the neurologist, few presentations are as diagnostically challenging as recurrent, unexplained syncope and falls. While the differential diagnosis is broad—ranging from cardiogenic etiologies to structural neurologic deficits—autonomic dysfunction is frequently under-recognized, particularly in aging populations and those with neurodegenerative diseases. Traditional workups often focus on ruling out life-threatening cardiac events, yet they frequently overlook subtle patterns of orthostatic intolerance or impaired vasomotor regulation that predispose patients to transient cerebral hypoperfusion.

The Role of Autonomic Testing in Syncope Evaluation

When a patient presents with recurrent episodes, the goal of syncope evaluation is to shift from reactive monitoring to proactive identification of physiological failure. Autonomic testing for syncope provides a nuanced view of the baroreflex arc, sympathetic tone, and parasympathetic activity that standard tilt-table tests or Holter monitors may miss. By systematically stressing the autonomic nervous system (ANS) through controlled maneuvers, clinicians can differentiate between vasovagal syncope and more complex autonomic failure.

Identifying Orthostatic Intolerance and Vasomotor Dysfunction

Autonomic dysfunction is a primary contributor to unexplained falls in the elderly. Often, these patients suffer from orthostatic hypotension or a failure of the compensatory vasoconstrictive response upon standing. Utilizing the VitalScan ANS+ system allows neurologists to measure real-time cardiovascular responses through Heart Rate Variability (HRV), the Valsalva ratio, and orthostatic blood pressure response. This data is critical for distinguishing between mechanical cardiac issues and the neural regulation failures that characterize autonomic dysfunction falls.

Integrating the VitalScan ANS+ in Clinical Practice

US MedResources has developed the VitalScan ANS+ as an FDA-cleared, non-invasive solution designed specifically to integrate into existing neurology workflows. Unlike complex legacy systems that require dedicated autonomic technicians, the ANS+ is engineered for simplicity, allowing existing clinical staff to administer the 15-minute diagnostic protocol.

Clinical Utility and Comprehensive Assessment

The device offers a multidimensional view of patient health, encompassing:

• Autonomic Function: HRV, Valsalva ratio, and orthostatic blood pressure assessment.
• Sudomotor Integrity: Utilizing the SudoCheck feature to assess peripheral nerve function.
• Vascular Health: Quantitative assessment of Pulse Wave Velocity (PWV) and Ankle-Brachial Index (ABI) to assess arterial stiffness and peripheral perfusion.

By providing an automated, interpretative report before the patient departs, the physician can deliver immediate clinical insights and adjust treatment plans—such as medication titration or lifestyle modifications—without the delay of third-party interpretation.

Billing and Practice Sustainability

Adopting autonomic diagnostics is not only a clinical benefit but a strategic practice decision. The VitalScan ANS+ supports robust billing protocols through CPT codes 95921-95924 for autonomic nervous system testing, as well as 93922-93971 for comprehensive vascular studies. This reimbursement framework allows practices to offer high-value, evidence-based care while maintaining sustainable overhead.

Aligning with Clinical Guidelines

Recent guidelines from major cardiovascular and neurological organizations, including the AHA and ACC, emphasize that a comprehensive syncope evaluation must include an assessment of autonomic failure. By leveraging data-driven diagnostics, neurologists can better align with these standards, reducing the diagnostic odyssey for patients who suffer from chronic orthostatic intolerance and frequent, injurious falls. Given the 30-year track record of US MedResources in this space, the VitalScan ANS+ platform offers a reliable, evidence-based pathway to improving diagnostic accuracy.

Key Takeaway

Unexplained falls and syncope in neurologic patients often stem from silent autonomic failure. Incorporating the VitalScan ANS+ allows for a 15-minute, office-based assessment of autonomic and vascular function, enabling precise identification of orthostatic and vasomotor dysfunction. This empowers neurologists to improve patient safety, optimize treatment protocols, and utilize established billing codes (95921-95924 and 93922-93971) to enhance practice revenue while providing superior, data-driven diagnostic care.